Association of Symptomatic Benign Prostatic Hyperplasia and Prostate Cancer: Results from the Prostate Cancer Prevention Trial
Open Access
- 3 May 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 173 (12), 1419-1428
- https://doi.org/10.1093/aje/kwq493
Abstract
This study examined the association between symptomatic benign prostatic hyperplasia (BPH) and prostate cancer risk in 5,068 placebo-arm participants enrolled in the Prostate Cancer Prevention Trial (1993–2003). These data include 1,225 men whose cancer was detected during the 7-year trial—556 detected for cause (following abnormal prostate-specific antigen or digital rectal examination) and 669 detected not for cause (without indication), as well as 3,843 men who had biopsy-proven absence of prostate cancer at the trial end. Symptomatic BPH was assessed hierarchically as self-report of surgical or medical treatment, moderately severe symptoms (International Prostate Symptom Score >14), or physician diagnosis, and analyses were completed by BPH status at baseline (prevalent) or BPH prior to cancer diagnosis or study end (prevalent plus incident). Controlled for age, race, and body mass index, neither prevalent (risk ratio = 1.03, 95% confidence interval: 0.92, 1.14) nor prevalent plus incident (risk ratio = 0.96, 95% confidence interval: 0.87, 1.06) symptomatic BPH was associated with prostate cancer risk. This lack of association was consistent across subgroups defined by type of BPH-defining event (treatment, symptoms, or physician diagnosis), prompt for prostate cancer diagnosis, and prostate cancer grade. This study provides the strongest evidence to date that BPH does not increase the risk of prostate cancer.Keywords
This publication has 38 references indexed in Scilit:
- Biomarkers of Systemic Inflammation and Risk of Incident, Symptomatic Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention TrialAmerican Journal of Epidemiology, 2010
- Alcohol consumption, finasteride, and prostate cancer riskCancer, 2009
- Inflammation in prostate carcinogenesisNature Reviews Cancer, 2007
- Easy SAS Calculations for Risk or Prevalence Ratios and DifferencesAmerican Journal of Epidemiology, 2005
- Prostate carcinoma risk subsequent to diagnosis of benign prostatic hyperplasiaCancer, 2003
- The Impact of Systematic Prostate Biopsy on Prostate Cancer Incidence in Men With Symptomatic Benign Prostatic Hyperplasia Undergoing Transurethral Resection of the ProstateJournal of Urology, 1997
- Alcohol consumption, smoking, and other risk factors and prostate cancer in a large health plan cohort in California (United States)Cancer Causes & Control, 1994
- Natural history of benign prostatic hyperplasia (BPH)The Prostate, 1989
- Zonal Distribution of Prostatic AdenocarcinomaThe American Journal of Surgical Pathology, 1988
- Latent Prostatic Cancer in a Consecutive Autopsy SeriesScandinavian Journal of Urology and Nephrology, 1980